Billionaire stock picks dELiA*s, Inc. (NASDAQ:DLIA), AngloGold Ashanti Limited (ADR) (NYSE:AU) and Enzon Pharmaceuticals Inc (NASDAQ:ENZN) made big gains early in the day this Monday. Moving in the opposite direction are Corinthian Colleges Inc (NASDAQ:COCO), American Realty Capital Properties Inc (NASDAQ:ARCP) and Laboratory Corp. of America Holdings (NYSE:LH).
dELiA*s Climbs Despite Delisting Reports
dELiA*s, Inc. (NASDAQ:DLIA) climbed +36% early in the day, though today’s boost may not be enough to save it from delisting – which media outlets have suggested could be imminent. In the Tiger Global portfolio since the fourth quarter of 2013, DLIA has declined -83.25% year-to-date.
AngloGold Ashanti Limited (ADR) (NYSE:AU) gained +21.16% after reporting a sharp rise in profits for the third quarter. The gold mining company, a long-time John Paulson investment, is still down -14.51% for the year.
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) got a +12.09% boost early in the day, though it is still down -14.2% YTD. The biopharmaceutical company has been in Carl Icahn’s investment portfolio across several quarters, and fellow billionaire George Soros initiated a position in the firm in Q2.
American Realty Capital Properties Tumbles
Corinthian Colleges Inc (NASDAQ:COCO) dipped -9.78% this Monday. The for-profit educational company has faced a significant amount of criticism in recent months, and last week, yet another lawsuit was filed against the firm. The new Q2 Soros buy has declined -90.89% YTD.
American Realty Capital Properties Inc (NASDAQ:ARCP) fell -8.34% after this morning’s announcement that a deal with RCS Capital Corp. for the purchase of Cole Capital is off. ARCP, another Q2 acquisition for Soros, has lost -33.58% over the past month.
Laboratory Corp. of America Holdings (NYSE:LH) dipped -7.93% in the wake of news that it will buy Covance Inc. in a deal worth 6.1 billion. Despite today’s drop, the clinical laboratory company, a Ray Dalio holding, has gained +9.92% this year.